Vimarsana
Biggest News Aggregation in the World

Page 41 - Tak News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tak. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tak Today - Breaking & Trending Today

Altshuler Shaham Ltd Invests $2.25 Million in Takeda Pharmaceutical Company Limited (NYSE:TAK) - Vimarsana News

Altshuler Shaham Ltd Invests $2.25 Million in Takeda Pharmaceutical Company Limited (NYSE:TAK)

Altshuler Shaham Ltd bought a new position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK – Free Report) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 136,348 shares of the company’s stock, valued at approximately $2,247,000. Other hedge funds have also modified […]

Learning about the wild men of Borneo ... in Chiang Mai - Vimarsana News

Learning about the wild men of Borneo ... in Chiang Mai

The historical connection between Sarawak and Thailand involves a Rajah, a King and a Sultan.

Discovering the wild men of Borneo…in Chiang Mai | Borneo Bulletin Online - Vimarsana News

Discovering the wild men of Borneo…in Chiang Mai | Borneo Bulletin Online

CHIANG MAI (ANN/THE STAR) – In a matter of days, I visited the Rajah Brooke’s Museum in Kuching, Sarawak and then travelled to Chiang Mai in northern Thailand. The museum provides a wonderful background on members of the Brooke Family, who ruled over Sarawak from 1841 to 1946 as the White Rajahs. The family’s legacy […]

20 Cities in Thailand To Visit In 2023 - Vimarsana News

20 Cities in Thailand To Visit In 2023

From bustling Bangkok to other popular cities in Thailand like Chiang Mai, Pattaya and Phuket here's where to visit for a fantastic time.

Takeda Pharmaceutical (NYSE:TAK) Issues FY 2023 Earnings Guidance - Vimarsana News

Takeda Pharmaceutical (NYSE:TAK) Issues FY 2023 Earnings Guidance

Takeda Pharmaceutical (NYSE:TAK – Get Free Report) updated its FY 2023 earnings guidance on Thursday. The company provided EPS guidance of $3.16-$3.16 for the period. The company issued revenue guidance of $27.99 billion-$27.99 billion. Analysts Set New Price Targets Several equities analysts recently commented on the stock. TheStreet upgraded shares of Takeda Pharmaceutical from a […]